STEMI - Nursing Case Study
Pathophysiology
• Primary mechanism: Rupture of an atherosclerotic plaque within a coronary artery leads to acute thrombus formation, causing complete occlusion of the vessel and cessation of blood flow to the myocardial tissue.
• Secondary mechanism: Prolonged ischemia due to the obstruction results in necrosis of myocardial cells, initiating an inflammatory response and release of cardiac biomarkers such as troponins.
• Key complication: The resultant myocardial infarction can lead to severe complications such as ventricular arrhythmias, heart failure, or cardiogenic shock due to the loss of contractile function and electrical instability of the affected myocardium.
Patient Profile
Demographics:
62-year-old male, construction worker
History:
• Key past medical history: Hypertension, Type 2 Diabetes Mellitus, Hyperlipidemia, Chronic Kidney Disease Stage 3
• Current medications: Metformin, Lisinopril, Atorvastatin, Aspirin
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Severe chest pain radiating to the left arm and jaw
• Key symptoms: Diaphoresis, nausea, shortness of breath, dizziness
• Vital signs: Blood pressure 85/50 mmHg, heart rate 120 bpm, respiratory rate 28 breaths/min, oxygen saturation 88% on room air, temperature 37.1°C
Section 1
As the emergency department team initiates care for the 62-year-old male construction worker, his condition evolves rapidly. Initial assessment reveals jugular venous distention and crackles upon auscultation of the lungs, suggesting acute left-sided heart failure. The patient is diaphoretic and pale, with an altered level of consciousness, which raises concerns for cardiogenic shock. Electrocardiogram results confirm ST-segment elevation in the anterior leads, consistent with an anterior wall ST-Elevation Myocardial Infarction (STEMI). Despite supplemental oxygen, his saturation remains at 88%, indicating significant respiratory compromise.
The laboratory results return, showing markedly elevated troponin levels, confirming myocardial injury. Additionally, the patient's renal function has deteriorated, with a creatinine level rising to 2.8 mg/dL, exacerbating his chronic kidney disease. Electrolyte imbalances are evident, with hyperkalemia (potassium level of 5.8 mEq/L) posing an additional risk for life-threatening arrhythmias. The patient is swiftly transferred to the cardiac catheterization lab for emergent percutaneous coronary intervention (PCI) to restore coronary blood flow.
During the PCI, the patient develops a new complication: ventricular tachycardia, likely due to the extensive myocardial damage and ongoing ischemia. The rapid sequence of ventricular beats causes further hemodynamic instability, necessitating immediate defibrillation and initiation of intravenous antiarrhythmic therapy. The interventional cardiologist successfully revascularizes the occluded vessel with a drug-eluting stent, but the patient's hemodynamic state remains precarious, requiring the critical care team to initiate vasopressor support and consider mechanical circulatory support options such as an intra-aortic balloon pump to manage the severe cardiogenic shock. This series of events demands advanced clinical reasoning and swift decision-making to navigate the complex interplay of acute myocardial infarction, heart failure, and arrhythmia management.
Section 2
As the patient is stabilized post-PCI, the critical care team closely monitors his condition in the intensive care unit. Despite the successful revascularization, the patient's hemodynamic instability persists. His blood pressure remains critically low at 78/48 mmHg despite vasopressor support with norepinephrine, and his heart rate fluctuates between 110-130 beats per minute. The team decides to implement an intra-aortic balloon pump to augment cardiac output and improve coronary perfusion. Concurrently, the patient's respiratory status deteriorates further, with arterial blood gas analysis revealing a pH of 7.28, PaCO2 of 55 mmHg, and PaO2 of 60 mmHg, indicating acute respiratory acidosis and an urgent need for intubation and mechanical ventilation.
The patient's renal function continues to decline, with a creatinine level climbing to 3.5 mg/dL, suggesting acute kidney injury superimposed on his chronic kidney disease. Additionally, the hyperkalemia has worsened, now at 6.3 mEq/L, increasing the risk for recurrent arrhythmias. The nephrology team is consulted for renal replacement therapy options, and the decision is made to initiate continuous renal replacement therapy (CRRT) to address the electrolyte imbalance and fluid overload, while minimizing the risk of rapid fluid shifts that could further compromise cardiac function.
Amidst these challenges, the nursing team observes new signs of peripheral cyanosis and mottling, raising concerns for worsening perfusion and potential multi-organ dysfunction syndrome (MODS). The critical care nurse must now integrate these findings into the overall clinical picture, considering the interplay of cardiogenic shock, respiratory failure, and renal impairment. This situation demands precise titration of medications, vigilant monitoring for signs of organ system decline, and proactive communication with the multidisciplinary team to coordinate care strategies that can stabilize the patient and prevent further deterioration.
Section 3
As the critical care team continues to manage the complex case of the patient with STEMI and multiple complications, they focus on the ongoing hemodynamic instability despite the implementation of the intra-aortic balloon pump. Despite initial expectations for improvement, the patient's blood pressure remains perilously low at 82/50 mmHg. Additionally, the heart rate has stabilized somewhat but remains tachycardic at 118 beats per minute. The patient's skin remains cool and clammy, with persistent peripheral cyanosis and mottling, indicative of inadequate perfusion. The team is concerned about the possibility of distributive shock contributing to the hemodynamic instability, potentially as a result of systemic inflammatory response.
New diagnostic results from a recent echocardiogram reveal a significant decrease in left ventricular ejection fraction, now measured at 25%, suggesting severe systolic dysfunction. This finding correlates with the patient's ongoing cardiogenic shock and indicates a high risk for further cardiac complications. Moreover, the recent chest X-ray shows diffuse bilateral infiltrates, raising the suspicion of acute respiratory distress syndrome (ARDS) contributing to the respiratory failure. The arterial blood gas analysis post-intubation shows a pH of 7.25, PaCO2 of 58 mmHg, and PaO2 of 65 mmHg, confirming persistent respiratory acidosis despite mechanical ventilation, necessitating adjustments in ventilatory settings and possibly the need for additional pulmonary support strategies.
In light of these developments, the critical care nurse must now prioritize interventions that can stabilize the patient's cardiac function while simultaneously managing the evolving respiratory and renal challenges. This involves careful titration of the intra-aortic balloon pump, optimizing ventilator settings to improve gas exchange, and coordinating closely with the nephrology team to effectively manage the CRRT. As the patient's condition continues to evolve, the multidisciplinary team must remain vigilant for signs of further organ dysfunction, ready to adapt their strategies to prevent progression to multi-organ dysfunction syndrome. The complexity of the case underscores the importance of advanced clinical reasoning and the need for continuous assessment and adaptation of the treatment plan.
Section 4
As the critical care team continues to monitor the patient's status, they observe a troubling change in clinical condition, signaling potential new complications. Over the past few hours, the patient has developed oliguria, with urine output dropping to less than 15 mL/hour, indicating possible acute kidney injury (AKI) on top of the existing challenges. Laboratory results reveal a rising serum creatinine level, now at 2.8 mg/dL, and elevated blood urea nitrogen (BUN) at 48 mg/dL, suggesting worsening renal function. The nephrology team is consulted urgently to evaluate the need for adjustments in the continuous renal replacement therapy (CRRT) settings to address fluid overload and electrolyte imbalances, particularly hyperkalemia, with potassium levels now at 5.8 mEq/L.
Simultaneously, the patient's neurological status is deteriorating, with a decrease in Glasgow Coma Scale (GCS) score from 14 to 10, characterized by an inability to follow commands and increased somnolence. The team suspects that cerebral hypoperfusion due to ongoing hemodynamic instability might be contributing to altered mental status. A STAT head CT is ordered to rule out any acute intracranial pathology, such as hemorrhage or stroke, as a potential cause of the neurological decline.
These developments necessitate an urgent reassessment of the patient's overall treatment strategy. The team deliberates on escalating pharmacological support with vasopressors such as norepinephrine to improve cerebral and renal perfusion, while cautiously balancing the risks of increased myocardial oxygen demand. Additionally, they consider revisiting the ventilator strategy to optimize oxygenation and carbon dioxide clearance, aiming to improve both respiratory and cerebral outcomes. The unfolding scenario demands precise and dynamic clinical decision-making to prevent further deterioration and guide the patient towards stabilization.
Section 5
Response to Interventions:
Following the initiation of norepinephrine, the patient's mean arterial pressure (MAP) shows a modest improvement, rising to 65 mmHg, which is encouraging for cerebral and renal perfusion. However, this comes with a trade-off, as the patient begins to exhibit signs of increased myocardial strain, evidenced by a slight elevation in troponin levels from 0.15 ng/mL to 0.18 ng/mL and a heart rate climbing to 110 bpm. The team must carefully titrate the vasopressor dosage, balancing the need to maintain adequate perfusion against the risk of exacerbating myocardial ischemia.
On the ventilator front, adjustments are made to optimize oxygenation. The ventilator settings are recalibrated to maintain a PaO2 of 75 mmHg and a PaCO2 of 40 mmHg, reflecting improved gas exchange. Concurrently, the nephrology team initiates adjustments in the CRRT settings to better manage fluid overload and address the hyperkalemia, which now shows a slight decrease to 5.5 mEq/L after initial treatment with calcium gluconate and insulin with dextrose.
Despite these interventions, the patient's neurological status remains a concern. The repeat GCS assessment shows no improvement, prompting a re-evaluation of the head CT findings, which confirm no acute intracranial events. This suggests that the patient's altered mental status may indeed be linked to systemic factors such as persistent cerebral hypoperfusion or metabolic disturbances. The critical care team must now consider additional strategies, possibly including further optimization of hemodynamics or exploring alternative causes for the neurological decline, to prevent further deterioration and guide the patient toward stabilization.